Evidence map›Paper›PMID 31099158›Full record

ArticleGenes to cells : devoted to molecular & cellular mechanisms2019

Highly efficient induction of primate iPS cells by combining RNA transfection and chemical compounds.

Toshiaki Watanabe, Shun Yamazaki, Nao Yoneda, Haruka Shinohara, Ikuo Tomioka, Yuichiro Higuchi, Mika Yagoto, Masatsugu Ema, Hiroshi Suemizu, Kenji Kawai and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Genes to cells : devoted to molecular & cellular mechanisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Genome-wide integration of microRNA and transcriptomic profiles of differentiating human alveolar epithelial cells.American journal of physiology. Lung cellular and molecular physiology · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Toshiaki WatanabeCentral Institute for Experimental Animals, Kawasaki, Japan.
Shun YamazakiCentral Institute for Experimental Animals, Kawasaki, Japan.
Nao YonedaCentral Institute for Experimental Animals, Kawasaki, Japan.
Haruka ShinoharaCentral Institute for Experimental Animals, Kawasaki, Japan.
Ikuo TomiokaLaboratory of Applied Reproductive Science, Faculty of Agriculture, Shinshu University, Matsumoto, Japan.
Yuichiro HiguchiCentral Institute for Experimental Animals, Kawasaki, Japan.
Mika YagotoCentral Institute for Experimental Animals, Kawasaki, Japan.
Masatsugu EmaDepartment of Stem Cells and Human Disease Models, Research Center for Animal Life Science, Shiga University of Medical Science, Shiga, Japan.
Hiroshi SuemizuCentral Institute for Experimental Animals, Kawasaki, Japan.
Kenji KawaiCentral Institute for Experimental Animals, Kawasaki, Japan.
Erika SasakiCentral Institute for Experimental Animals, Kawasaki, Japan.ORCID https://orcid.org/0000-0002-0415-5400
Central Institute for Experimental Animals · JPShiga University of Medical Science · JPShinshu University · JP

Funding

Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and development (AMED)Maintenance of Systems for Creation and Spread of Primate Model Animals" from AMEDMinistry of Education 15H02360Ministry of Education, Culture, Sports, Science and Technology of Japan MEXT/JSPS KAKENHI 15H02360Strategic Research Program for Brain Science
6 · The paper itself

Abstract

Induced pluripotent stem (iPS) cells hold great promise for regenerative medicine and the treatment of various diseases. Before proceeding to clinical trials, it is important to test the efficacy and safety of iPS cell-based treatments using experimental animals. The common marmoset is a new world monkey widely used in biomedical studies. However, efficient methods that could generate iPS cells from a variety of cells have not been established. Here, we report that marmoset cells are efficiently reprogrammed into iPS cells by combining RNA transfection and chemical compounds. Using this novel combination, we generate transgene integration-free marmoset iPS cells from a variety of cells that are difficult to reprogram using conventional RNA transfection method. Furthermore, we show this is similarly effective for human and cynomolgus monkey iPS cell generation. Thus, the addition of chemical compounds during RNA transfection greatly facilitates reprogramming and efficient generation of completely integration-free safe iPS cells in primates, particularly from difficult-to-reprogram cells.

Indexed as

Cellular ReprogrammingAgedAnimalsCell DifferentiationCells, CulturedFemaleFibroblastsHumansInduced Pluripotent Stem CellsPharmaceutical PreparationsPlatyrrhiniRNATransfectionPharmaceutical PreparationsRNAchemical compoundsES cellhumansinterferon responseiPS cellmarmosetsmiRNAmRNAprimatesRNA transfection

Identifiers

PMID31099158
PMCPMC6852476
OpenAlexW2945918839

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.